open access
LRRK2 R1441C mutation causing Parkinson’s Disease in an Egyptian family
- Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, United States
open access
Abstract
Abstract
Keywords
Egyptian, leucine-rich repeat kinase 2 gene, Parkinson’s Disease, R1441C mutation
Title
LRRK2 R1441C mutation causing Parkinson’s Disease in an Egyptian family
Journal
Neurologia i Neurochirurgia Polska
Issue
Article type
Letter to the Editors
Pages
191-192
Published online
2022-01-14
Page views
4948
Article views/downloads
549
DOI
Pubmed
Bibliographic record
Neurol Neurochir Pol 2022;56(2):191-192.
Keywords
Egyptian
leucine-rich repeat kinase 2 gene
Parkinson’s Disease
R1441C mutation
Authors
Shan Ali
Zbigniew K Wszolek
- Peng F, Sun YM, Chen C, et al. The heterozygous R1441C mutation of leucine-rich repeat kinase 2 gene in a Chinese patient with Parkinson disease: a five-year follow-up and literatures review. J Neurol Sci. 2017; 373: 23–26.
- Srivatsal S, Cholerton B, Leverenz JB, et al. Cognitive profile of LRRK2-related Parkinson's disease. Mov Disord. 2015; 30(5): 728–733.
- Milanowski ŁM, Ross OA, Friedman A, et al. Genetics of Parkinson's disease in the Polish population. Neurol Neurochir Pol. 2021; 55(3): 241–252.
- Benamer HTS, de Silva R. LRRK2 G2019S in the North African population: a review. Eur Neurol. 2010; 63(6): 321–325.
- Fiandaca MS, Lonser RR, Elder JB, et al. Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders. Neurol Neurochir Pol. 2020; 54(3): 220–231.